Pro B-type natriuretic peptide stongly predicts all cause and cardiovascular mortality in peripheral arterial disease patients with as well as in those without type 2 diabetes

被引：0
|
作者：
Zanolin, Daniela [1 ]
Rein, Philipp [1 ,2 ]
Saely, Christoph [1 ,2 ,3 ]
Vonbank, Alexander [1 ,2 ]
Lins, Christina [1 ]
Leiherer, Andreas [1 ,3 ]
Muendlein, Axel [1 ]
Schuler, Alexandra [1 ,2 ]
Ebner, Karl-Martin [1 ,2 ]
Schwerzler, Peter [1 ,2 ]
Mader, Arthur [1 ,2 ]
Drexel, Heinz [1 ,3 ,4 ]
机构：
[1] VIVIT Inst, Feldkirch, Austria
[2] Acad Teaching Hosp, Feldkirch, Austria
[3] Private Univ Principal Liechtenstein, Triesen, Liechtenstein
[4] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA
来源：
WIENER KLINISCHE WOCHENSCHRIFT | 2017年 / 129卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P21
引用
收藏
页码：S127 / S127
页数：1
相关论文
共 50 条
  • [1] Pro B-type natriuretic peptide strongly predicts all cause and cardiovascular mortality in peripheral arterial disease patients with as well as in those without type 2 diabetes
    Zanolin, Daniela
    Saely, Christoph
    Vonbank, Alexander
    Lins, Christina
    Leiherer, Andreas
    Muendlein, Axel
    Ebner, Karl-Martin
    Schwerzler, Peter
    Mader, Arthur
    Heinzle, Christine
    Drexel, Heinz
    WIENER KLINISCHE WOCHENSCHRIFT, 2017, 129 : 166 - 167
  • [2] Pro B-type natriuretic peptide strongly predicts all cause and cardiovascular mortality in peripheral arterial disease patients with as well as in those without type 2 diabetes
    Mader, A.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2018, 48 : 153 - 153
  • [3] Pro-B-type Natriuretic Peptide Strongly Predicts All Cause and Cardiovascular Mortality in Peripheral Arterial Disease Patients With as well as in Those Without Type 2 Diabetes
    Zanolin, Daniela
    Rein, Philipp
    Saely, Christoph H.
    Vonbank, Alexander
    Lins, Christina
    Leiherer, Andreas
    Muendlein, Axel
    Schuler, Alexandra
    Ebner, Karl-Martin
    Drexel, Heinz
    DIABETES, 2017, 66 : A403 - A404
  • [4] PRO-B-TYPE NATRIURETIC PEPTIDE STRONGLY PREDICTS ALL CAUSE AND CARDIOVASCULAR MORTALITY IN PERIPHERAL ARTERIAL DISEASE PATIENTS WITH AS WELL AS IN THOSE WITHOUT TYPE 2 DIABETES
    Zanolin, D.
    Saely, C. H.
    Vonbank, A.
    Lins, C.
    Leiherer, A.
    Mader, A.
    Larcher, B.
    Muendlein, A.
    Drexel, H.
    ATHEROSCLEROSIS, 2018, 275 : E203 - E203
  • [5] Pro-B-Type Natriuretic Peptide Strongly Predicts Major Cardiovascular Events and Mortality in Cardiovascular Disease Patients with Type 2 Diabetes as Well as in Those without Diabetes
    Maechler, Maximilian
    Sprenger, Lukas
    Mader, Arthur
    Larcher, Barbara
    Vonbank, Alexander
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    Saely, Christoph H.
    DIABETES, 2022, 71
  • [6] PRO-B-TYPE NATRIURETIC PEPTIDE STRONGLY PREDICTS MAJOR CARDIOVASCULAR EVENTS AND MORTALITY IN CARDIOVASCULAR DISEASE PATIENTS WITH TYPE 2 DIABETES AS WELL AS IN THOSE WITHOUT DIABETES
    Maechler, M.
    Sprenger, L.
    Mader, A.
    Larcher, B.
    Vonbank, A.
    Plattner, T.
    Leiherer, A.
    Muendlein, A.
    Drexel, H.
    Saely, C.
    ATHEROSCLEROSIS, 2023, 379 : S188 - S188
  • [7] Pro-B-Type Natriuretic Peptide Strongly Predicts Future Cardiovascular Events in Cardiovascular Disease Patients with Type 2 Diabetes as Well as in Those Without Type 2 Diabetes
    Saely, Christoph H.
    Vonbank, Alexander
    Heinzle, Christine
    Zanolin, Daniela
    Larcher, Barbara
    Mader, Arthur
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    DIABETES, 2018, 67
  • [8] PRO-B-TYPE NATRIURETIC PEPTIDE STRONGLY PREDICTS FUTURE CARDIOVASCULAR EVENTS IN CARDIOVASCULAR DISEASE PATIENTS WITH TYPE 2 DIABETES AS WELL AS IN THOSE WITHOUT TYPE 2 DIABETES
    Saely, C. H.
    Vonbank, A.
    Heinzle, C.
    Purin, D.
    Larcher, B.
    Mader, A.
    Leiherer, A.
    Muendlein, A.
    Drexel, H.
    ATHEROSCLEROSIS, 2019, 287 : E189 - E189
  • [9] Pro-B-type natriuretic peptide strongly predicts future cardiovascular events in cardiovascular disease patients with type 2 diabetes as well as in those without type 2 diabetes
    Saely, C. H.
    Vonbank, A.
    Heinzle, C.
    Zanolin, D.
    Larcher, B.
    Mader, A.
    Ebner, K-M.
    Leiherer, A.
    Muendlein, A.
    Drexel, H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2018, 130 : 100 - 100
  • [10] Pro-B-type natriuretic peptide strongly predicts future cardiovascular events in cardiovascular disease patients with type 2 diabetes as well as in those without type 2 diabetes
    Mader, Arthur
    Saely, Christoph
    Vonbank, Alexander
    Heinzle, Christine
    Zanolin-Purin, Daniela
    Larcher, Barbara
    Leiherer, Andreas
    Muendlein, Doz Axel
    Drexel, Heinz
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2019, 49 : 156 - 156
12345